The PanVax Tool to Improve Pandemic Influenza Emergency Vaccination Program Readiness and Partnership

Cristina Carias1, Jonathan D Lehnert1, Bradford Greening1

  • 1Cristina Carias, Bradford Greening Jr, Emily B. Kahn, and Martin I. Meltzer are with the Health Economics and Modeling Unit, Division of Preparedness and Emerging Infections, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA. Jonathan D. Lehnert, Bishwa B. Adhikari, and Samuel B. Graitcer are with the Immunization Services Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention. Jonathan D. Lehnert is also with IHRC, Atlanta.

Related Concept Videos

Intranasal Administration of Recombinant Influenza Vaccines in Chimeric Mouse Models to Study Mucosal Immunity10:39

Intranasal Administration of Recombinant Influenza Vaccines in Chimeric Mouse Models to Study Mucosal Immunity

There is an overall lack of knowledge about how vaccines work. Here we propose the combined use of reverse genetics and bone marrow chimeric mice to gain insight into the early host immune responses to vaccines with a special focus on dendritic cells and T cell...
13.1K
Generating Recombinant Live-Attenuated Influenza Viruses for Vaccines02:58

Generating Recombinant Live-Attenuated Influenza Viruses for Vaccines

The video showcases a method to create cold-adapted recombinant influenza viruses. It involves transfecting human cells with bi-directional plasmids, followed by incubation at lower temperature incubation to yield viruses suitable for vaccine production, characterized by reduced replication in warmer...
609
Measuring Influenza Neutralizing Antibody Responses to A(H3N2) Viruses in Human Sera by Microneutralization Assays Using MDCK-SIAT1 Cells12:09

Measuring Influenza Neutralizing Antibody Responses to A(H3N2) Viruses in Human Sera by Microneutralization Assays Using MDCK-SIAT1 Cells

Influenza neutralizing antibodies correlate with protection of influenza infections. Microneutralization assays measure neutralizing antibodies in human sera and are often used for influenza human serology. We describe a microneutralization assay using MDCK-SIAT1 cells to measure neutralizing antibody titers to contemporary 3C.2a and 3C.3a A(H3N2) viruses following influenza vaccination or...
18.7K
Vaccinations01:51

Vaccinations

Overview
51.3K
Partnership01:22

Partnership

In partnerships, the business is managed collectively by the partners, and profits and losses are shared according to the partnership agreement. Such business structures benefit from the diverse skills of each partner, leading to innovative ideas and strategies. Globally, partnerships are favored for their simplicity and flexibility. Various types of partnerships exist, including general partnerships, limited partnerships, and limited liability partnerships, each possessing unique...
408
Expression and Purification of Virus-like Particles for Vaccination06:17

Expression and Purification of Virus-like Particles for Vaccination

Here, we present a protocol for synthesizing virus-like particles using either baculovirus or mammalian expression systems, and ultracentrifugation purification. This highly customizable approach is used to identify viral antigens as vaccine targets in a safe and flexible...
22.7K